A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

The 10-minute procedure identified signs of acute myeloid leukaemia (AML) returning in patients before it showed in blood ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...

May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

Breeze Hunter thought she simply had a sinus infection she couldn’t kick. It was acute myeloid leukemia, a form of blood ...

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukaemia (AML) by helping ...

Abstract 1679, under the session ‘Drug Combination Strategies for Cancer Treatment’, showed that APG-2449, a novel focal ...